Πρόβα Terpsis Orchestra, "Οι κυρ-Μανώληδες" του Αντώνη Απέργη
Terpsis Orchestra (Πρόβα 2024-04-21) - "Οι κυρ-Μανώληδες" του Αντώνη Απέργη
YouTube video by SonicVisual
youtu.be
November 21, 2024 at 10:07 AM
Πρόβα Terpsis Orchestra, "Οι κυρ-Μανώληδες" του Αντώνη Απέργη
#Anhedonia - the inability to feel pleasure - is a core symptom of major depressive disorder and remains challenging to treat. The phase 2 #TERPSIS study evaluated NBI-1065846, a novel experimental #GPR139 #agonist targeting the #lateral #habenula.
🔗 Read more: journals.lww.com/psychopharma...
🔗 Read more: journals.lww.com/psychopharma...
September 10, 2025 at 4:29 PM
#Anhedonia - the inability to feel pleasure - is a core symptom of major depressive disorder and remains challenging to treat. The phase 2 #TERPSIS study evaluated NBI-1065846, a novel experimental #GPR139 #agonist targeting the #lateral #habenula.
🔗 Read more: journals.lww.com/psychopharma...
🔗 Read more: journals.lww.com/psychopharma...
Eunoia
Metanoia
Ataraxia
Kairos
Terpsis
Eudaimonia
Metanoia
Ataraxia
Kairos
Terpsis
Eudaimonia
I have to stop thinking of names for a boat I don't own and won't buy.
November 4, 2025 at 4:24 AM
Eunoia
Metanoia
Ataraxia
Kairos
Terpsis
Eudaimonia
Metanoia
Ataraxia
Kairos
Terpsis
Eudaimonia
"Museum" was the first in a triptych. The two other sculptures being "Academy" and "Temple". The set reflects the ideas of three ancient philosophers - Aristotle, Plato, and Pythagoras via a poem by Yeats. The choice of objects in "Museum" was informed by the etymology of the Muses' names.
June 6, 2025 at 9:13 PM
"Museum" was the first in a triptych. The two other sculptures being "Academy" and "Temple". The set reflects the ideas of three ancient philosophers - Aristotle, Plato, and Pythagoras via a poem by Yeats. The choice of objects in "Museum" was informed by the etymology of the Muses' names.
The TERPSIS study was a phase 2, randomized clinical trial that evaluated the efficacy of the investigational drug NBI-1065846 (TAK-041) in improving anhedonia, depression, and anxiety in adults with major depressive disorder.
August 21, 2025 at 8:40 AM
The TERPSIS study was a phase 2, randomized clinical trial that evaluated the efficacy of the investigational drug NBI-1065846 (TAK-041) in improving anhedonia, depression, and anxiety in adults with major depressive disorder.